Predictive modeling in colorectal cancer: time to move beyond consensus molecular subtypes

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2019-11, Vol.30 (11), p.1682-1685
Hauptverfasser:	Sveen, A., Cremolini, C., Dienstmann, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - pharmacology Bevacizumab - therapeutic use Biomarkers, Tumor - antagonists & inhibitors Biomarkers, Tumor - genetics Camptothecin - analogs & derivatives Camptothecin - pharmacology Camptothecin - therapeutic use Cetuximab - pharmacology Cetuximab - therapeutic use Colorectal Neoplasms - drug therapy Colorectal Neoplasms - genetics Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Consensus Female Fluorouracil - pharmacology Fluorouracil - therapeutic use Gene Expression Profiling - standards Gene Expression Regulation, Neoplastic Genetic Heterogeneity Humans Leucovorin - pharmacology Leucovorin - therapeutic use Male Middle Aged Models, Biological Molecular Targeted Therapy - methods Patient Selection Progression-Free Survival Randomized Controlled Trials as Topic Tumor Microenvironment - drug effects Tumor Microenvironment - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!